Key Takeaway: Vanda Pharmaceuticals Inc. has announced its participation in the upcoming J.P. Morgan Healthcare Conference on January 15, 2026. The corporate presentation will be accessible live on the company's website, allowing investors to engage directly. This event highlights Vanda's commitment to addressing unmet medical needs through innovative therapies.
Price reaction · baseline $6.6 (2025-12-11 close) · hit after-hours · 1 other VNDA headline(s) in the window, move may be shared
day 0 close · peak
-5.6%
day 1
+0.5%
day 3
+3.3%
Market Sentiment Analysis
POSITIVE FACTORS
Vanda Pharmaceuticals is participating in a prestigious healthcare conference.
The company aims to showcase its innovative therapies.
Live access to the presentation enhances investor engagement.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+121%
120-day peak, hindsight
Typical move
19.9%
average across 7 past catalysts
Cash runway
~16 mo
Low dilution risk
Lead asset
Imsidolimab
Phase 2 · Palmoplantar Pustulosis
Full Press Release Details
WASHINGTON,Dec. 11, 2025/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq:VNDA) today announced that the company will participate in the J.P. Morgan Healthcare Conference in San Francisco, California on Thursday, January 15, 2026. A corporate presentation is scheduled for 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time).
The corporate presentation given at the J.P. Morgan Healthcare Conference may be accessed live on Vanda's corporate website,www.vandapharma.com. Investors should click on the Investors tab and follow the link under Recent Events. Investors are advised to go to the conference website at least 15 minutes early to register, download, and install any necessary software or presentations. A link to the archived conference will be available on Vanda's website for a period of approximately 30 days.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visitwww.vandapharma.comand follow us on X @vandapharma.